G LP-1 drugs containing semaglutide (the active ingredient in Ozempic and Wegovy) have exploded in popularity for their ...

Research suggests potential health benefits beyond what popular diabetes and weight-loss drugs were first approved to treat.

Recent research throws into question whether GLP-1 drugs increase the risk of certain types of thyroid cancer.

Ozempic and similar GLP-1 weight-loss medications are designed to be a lifelong treatment. But a new study finds the majority ...

Weight loss drugs like Ozempic deliver more health benefits than expected.

With semaglutide shortages in the rearview, Novo Nordisk is doubling down on marketing efforts for its GLP-1 drugs.

Ozempic is approved to reduce the risk of heart attack or stroke in people with type 2 diabetes and heart disease. It’s also approved to reduce the risk of kidney disease progression or heart ...

Novo Nordisk launched "My Ozempic® Era" today, a national campaign which spotlights the longstanding Ozempic® patient ...

Popular weight-loss drugs like Ozempic and Wegovy are known for helping people who are looking to shed some pounds, but research suggests they could offer other life-changing benefits. Dr. Natalie ...